MNX1-overexpressing haemGx showed expansion of cells at the HE-to-EMP transition, which became susceptible to transformation in vitro and recapitulated MNX1-r AML patient signatures, placing MNX1’s leukemogenic effects at a very early stage of developmental blood formation. The gene discussed is MNX1; the disease is acute myeloid leukemia.